LNTH - Lantheus Holdings, Inc.
77.84
-1.000 -1.285%
Share volume: 916,089
Last Updated: 03-04-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$78.84
-1.00
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 07-31-2024 | 11-06-2024 | 02-26-2025 | 05-07-2025 | 08-06-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 369.975 M | 394.091 M | 378.734 M | 391.110 M | 372.764 M | 378.045 M | 384.014 M | -1.135 B | |
| Cost of revenue | 128.129 M | 138.317 M | 136.608 M | 142.565 M | 135.064 M | 137.034 M | 161.648 M | -1.376 B | |
| Gross profit | 241.846 M | 255.774 M | 242.126 M | 248.545 M | 237.700 M | 241.011 M | 222.366 M | 240.875 M | |
| 5.76% | -5.34% | 2.65% | -4.36% | 1.39% | -7.74% | 8.32% | |||
| Operating expenses | 95.919 M | 108.010 M | 64.664 M | 93.194 M | 93.130 M | 112.004 M | 129.923 M | 117.372 M | |
| Selling general and admin | 47.895 M | 47.409 M | 40.516 M | 57.869 M | 56.816 M | 66.515 M | 81.898 M | 69.892 M | |
| Research and development | 48.024 M | 60.601 M | 24.148 M | 35.325 M | 36.314 M | 45.489 M | 48.025 M | 47.480 M | |
| Total expenses | 135.211 M | 153.045 M | 108.383 M | 134.673 M | 135.633 M | 153.045 M | 178.751 M | 163.691 M | |
| 13.19% | -29.18% | 24.26% | 0.71% | 12.84% | 16.80% | -8.43% | |||
| Operating income | 106.635 M | 102.729 M | 133.743 M | 113.872 M | 102.067 M | 87.966 M | 43.615 M | 77.184 M | |
| Ebit | 115.423 M | 111.773 M | 143.696 M | 123.318 M | 116.195 M | 94.861 M | 46.171 M | 84.931 M | |
| Pretax income | 171.268 M | 84.374 M | 176.118 M | -783.000 K | 96.529 M | 104.517 M | 42.381 M | 70.365 M | |
| -50.74% | 108.73% | -100.44% | -12,428.10% | 8.28% | -59.45% | 66.03% | |||
| Income tax | 40.202 M | 22.301 M | 45.025 M | 11.007 M | 23.584 M | 25.762 M | 14.610 M | 16.277 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 131.066 M | 62.073 M | 131.093 M | -11.790 M | 72.945 M | 78.755 M | 27.771 M | 54.088 M | |
| -52.64% | 111.19% | -108.99% | 718.70% | 7.96% | -64.74% | 94.76% |